Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer.
Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer. Mol Oncol. 2019 09; 13(9):1927-1943.
View in:
PubMed
subject areas
Cell Line, Tumor
Gene Expression Profiling
Head and Neck Neoplasms
Humans
Mevalonic Acid
Neoplasm Proteins
Proteomics
Quinolines
Radiation Tolerance
Radiation, Ionizing
Retrospective Studies
authors with profiles
Stephen J. Kron